We support world class medical research to improve health globally, addressing critical global health and societal challenges. By fostering equitable partnerships between scientists based in low and middle-income countries and the UK, we fund research to reduce health disparities and improve health outcomes.
MRC has a broad portfolio of global health investments, spanning the biomedical spectrum including:
- fundamental discovery research and mechanistic science
- early translational science
- population studies
- intervention development
Global health research is supported through all of MRC’s boards and panels.
Through our investments in global health research, we support a portfolio of high quality, high priority, diverse investments to improve health globally, encouraging:
- innovation in study design
- multi-disciplinarity to address global challenges
- diverse health topics: prioritising local relevance with potential for global impact
We also:
- prioritise equitable partnerships
- invest in research capacity strengthening
- promote co-design and co-production with communities, policymakers and health practitioners
MRC commitments to support global health research are underpinned by a longstanding relationship with the Foreign, Commonwealth and Development Office.